FDA Inspection 1237400 — Kimera Labs Inc
The FDA completed an inspection of Kimera Labs Inc on Aug 21, 2024 in Miramar, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 21, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Miramar, FL (United States)